Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Assess Efficacy and Safety of Neu2000KWL in Patients With Acute Ischemic Stroke Receiving Endovascular Therapy

NCT02831088 is registered in ClinicalTrials.gov with GNT Pharma as lead sponsor.

NCT NCT02831088
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02831088 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II, Double-blind, Randomized, Placebo-controlled, Multi-center Study to Assess Efficacy and Safety of Neu2000KWL in Patients With Acute Ischemic Stroke Receiving Endovascular Therapy
Lead sponsor
GNT Pharma
Phase
Phase 2
Overall status
Unknown status
Start date
July 31, 2016
Completion date
December 30, 2018
Enrollment
210 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

ischemic stroke